Gao Chenglong, Shi Wenchao, Zhang Baoming, Tang Qiang, Chen Huiyu, Bao Zengtao
Department of Gastrointestinal Surgery, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, 222016, PR China.
Department of Gastrointestinal Surgery, The First People's Hospital of Lianyungang, Lianyungang, 222016, PR China.
Langenbecks Arch Surg. 2025 Jun 3;410(1):173. doi: 10.1007/s00423-025-03760-2.
Surgery is considered a necessary treatment for gastric cancer (GC), but the extent of resection remains controversial. This study aimed to evaluate the efficacy of non-complete omentectomy (NCO) in GC patients undergoing radical gastrectomy.
We searched for studies of non-complete omentectomy versus complete omentectomy (CO) published before February 2024 from PubMed, Web of Science, and Cochrane Library databases. From the extracted clinical data, we compared surgical, survival, and recurrence outcomes between the two groups.
Thirteen studies with a total of 4255 patients were included. The meta-analysis showed that compared with the CO group, the NCO group was associated with a lower overall recurrence rate, shorter operative time, and fewer postoperative complications. However, there was no significant difference in the number of harvested lymph nodes and peritoneal recurrence rate between the two groups. The NCO group was associated with the higher 3-year overall survival (OS) rate (RR = 0.95, 95% CI = 0.91-0.99, P = 0.02), 5-year OS rate (RR = 0.91, 95% CI = 0.87-0.96, P = 0.0006), and 5-year relapse-free survival (RFS) rate (RR = 0.93, 95% CI = 0.87-0.99, P = 0.02). However, it was not associated with the 3-year RFS rate (RR = 0.95, 95% CI = 0.89-1.01, P = 0.12) compared with the CO group.
Regarding surgical, survival, and recurrence outcomes, performing NCO versus CO during radical gastrectomy provides no significant advantage. However, future high-quality and well-designed randomized controlled trials are necessary to validate the results.
手术被认为是胃癌(GC)的必要治疗方法,但切除范围仍存在争议。本研究旨在评估非完全网膜切除术(NCO)在接受根治性胃切除术的GC患者中的疗效。
我们检索了2024年2月之前在PubMed、科学网和考克兰图书馆数据库中发表的关于非完全网膜切除术与完全网膜切除术(CO)的研究。从提取的临床数据中,我们比较了两组之间的手术、生存和复发结果。
纳入了13项研究,共4255例患者。荟萃分析表明,与CO组相比,NCO组的总体复发率较低、手术时间较短且术后并发症较少。然而,两组之间的收获淋巴结数量和腹膜复发率没有显著差异。NCO组的3年总生存率(OS)率(RR = 0.95,95%CI = 0.91 - 0.99,P = 0.02)、5年OS率(RR = 0.91,95%CI = 0.87 - 0.96,P = 0.0006)和5年无复发生存率(RFS)率(RR = 0.93,95%CI = 0.87 - 0.99,P = 0.02)较高。然而,与CO组相比,它与3年RFS率(RR = 0.95,95%CI = 0.89 - 1.01,P = 0.12)无关。
在手术、生存和复发结果方面,在根治性胃切除术中进行NCO与CO相比没有显著优势。然而,未来需要高质量且设计良好的随机对照试验来验证结果。